These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3100425)

  • 21. Levofloxacin/imipenem prevents the emergence of high-level resistance among Pseudomonas aeruginosa strains already lacking susceptibility to one or both drugs.
    Lister PD; Wolter DJ; Wickman PA; Reisbig MD
    J Antimicrob Chemother; 2006 May; 57(5):999-1003. PubMed ID: 16513915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transduction of antibiotic resistance including imipenem resistance by wild type phages from nosocomial strains of Pseudomonas aeruginosa.
    Blahová J; Králiková K; Krcméry V; Mlynarcík D; Trupl J
    Acta Virol; 1997 Oct; 41(5):293-6. PubMed ID: 9607084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative in vitro activity of 5 beta-lactams (cefoperazone, cefsulodin, ceftazidime, azthreonam, N-formimidoyl-thienamycin) on 90 strains of Pseudomonas aeruginosa with various levels of resistance to ticarcillin].
    Le Noc P; Robert J; Le Noc D
    Pathol Biol (Paris); 1984 May; 32(5):404-7. PubMed ID: 6429611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa.
    Fournier D; Richardot C; Müller E; Robert-Nicoud M; Llanes C; Plésiat P; Jeannot K
    J Antimicrob Chemother; 2013 Aug; 68(8):1772-80. PubMed ID: 23587654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimising antibiotic dosing regimens based on pharmacodynamic target attainment against Pseudomonas aeruginosa collected in Hungarian hospitals.
    Ludwig E; Konkoly-Thege M; Kuti JL; Nicolau DP
    Int J Antimicrob Agents; 2006 Nov; 28(5):433-8. PubMed ID: 17046212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance emergence among P. aenrginosa in a rat thigh-abscess model. Comparison of imipenem and meropenem treatment.
    Karadenizli A; Kolayli F; Okay E; Ergen K; Oz S; Savli H; Leblebicioglu H; Vahaboglu H
    New Microbiol; 2003 Jul; 26(3):275-80. PubMed ID: 12901424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imipenem resistance in Pseudomonas aeruginosa resulting from diminished expression of an outer membrane protein.
    Büscher KH; Cullmann W; Dick W; Opferkuch W
    Antimicrob Agents Chemother; 1987 May; 31(5):703-8. PubMed ID: 3111361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of outer membrane protein OprD and penicillin-binding proteins in resistance of Pseudomonas aeruginosa to imipenem and meropenem.
    Farra A; Islam S; Strålfors A; Sörberg M; Wretlind B
    Int J Antimicrob Agents; 2008 May; 31(5):427-33. PubMed ID: 18375104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A novel carbapenem active against imipenem resistant strains of Pseudomonas aeruginosa].
    Sazykin YuO
    Antibiot Khimioter; 1997; 42(8):42. PubMed ID: 9412413
    [No Abstract]   [Full Text] [Related]  

  • 30. Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa.
    Lepper PM; Grusa E; Reichl H; Högel J; Trautmann M
    Antimicrob Agents Chemother; 2002 Sep; 46(9):2920-5. PubMed ID: 12183248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Host range variability in the transfer of antibiotic resistance determinants from Pseudomonas aeruginosa strains.
    Blahová J; Králiková K; Krcméry V; Schäfer V
    J Chemother; 2000 Jun; 12(3):199-203. PubMed ID: 10877513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ciprofloxacin interactions with imipenem and amikacin against multiresistant Pseudomonas aeruginosa.
    Giamarellou H; Petrikkos G
    Antimicrob Agents Chemother; 1987 Jun; 31(6):959-61. PubMed ID: 3113330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activity of imipenem against Pseudomonas and Bacteroides species.
    Williams JD
    Rev Infect Dis; 1985; 7 Suppl 3():S411-6. PubMed ID: 3931197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistance of Pseudomonas aeruginosa to imipenem is independent of beta-lactamase production.
    Büscher KH; Cullmann W; Opferkuch W
    J Antimicrob Chemother; 1987 May; 19(5):700-1. PubMed ID: 3112097
    [No Abstract]   [Full Text] [Related]  

  • 35. Mutation of Pseudomonas aeruginosa to piperacillin resistance mediated by beta-lactamase production.
    Bell SM; Pham JN; Lanzarone JY
    J Antimicrob Chemother; 1985 Jun; 15(6):665-70. PubMed ID: 3928573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imipenem-resistant Pseudomonas aeruginosa: risk factors and antibiotic susceptibility patterns.
    Troillet N; Samore MH; Carmeli Y
    Clin Infect Dis; 1997 Nov; 25(5):1094-8. PubMed ID: 9402364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of cross-resistance between imipenem and other beta-lactam antibiotics for Pseudomonas aeruginosa.
    Opferkuch W; Cullmann W
    Eur J Clin Microbiol; 1987 Jun; 6(3):330-2. PubMed ID: 3113943
    [No Abstract]   [Full Text] [Related]  

  • 38. Development of resistance in Pseudomonas aeruginosa to imipenem, norfloxacin, and ciprofloxacin during therapy: proof provided by typing with a DNA probe.
    Ogle JW; Reller LB; Vasil ML
    J Infect Dis; 1988 Apr; 157(4):743-8. PubMed ID: 3126247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transduction of imipenem resistance by wild-type bacteriophages carried by three strains of Pseudomonas aeruginosa isolated from a single source.
    Blahová J; Králiková K; Krcméry V; Mlynarcík D; Trupl J
    J Antimicrob Chemother; 1998 Jun; 41(6):660-2. PubMed ID: 9687107
    [No Abstract]   [Full Text] [Related]  

  • 40. Selection of resistance by piperacillin during Pseudomonas aeruginosa endocarditis.
    Letendre ED; Mantha R; Turgeon PL
    J Antimicrob Chemother; 1988 Oct; 22(4):557-62. PubMed ID: 3144526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.